# Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation

> **NCT01416935** · NA · TERMINATED · sponsor: **Inova Health Care Services** · enrollment: 186 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **OTHER:** No Amiodarone

## Key facts

- **NCT ID:** NCT01416935
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01-01
- **Primary completion:** 2015-01
- **Final completion:** 2016-07
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2022-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416935, "Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01416935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*